Company Information

Company Bristol-Myers Squibb
www.bms.com
Type:
Company
Country:
United States of America
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Publicly Listed
Global Compact Status:
Active
Participant Since
09 December 2010
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2024

Financial Information


Non-Financial Information

Communication On Progress

Published On Title Level/Status
2023-12-18 2023 Communication on Progress Submitted
2022-12-03 Bristol Myers Squibb 2022 Communication on Progress Advanced
2021-12-02 Bristol Myers Squibb 2021 Communication on Progress Advanced
2020-12-02 Communication on Progress Advanced
2019-12-02 Bristol-Myers Squibb 2019 Communication on Progress Advanced
2018-12-02 2018 Bristol-Myers Squibb Communication on Progress Advanced
2017-12-02 2017 Communication on Progress Active
2016-12-02 Communication on Progress Active
2015-12-03 2015 Communication on Progress Active
2014-12-03 2014 Communication on Progress Active
2013-12-03 2013 Communication on Progress Active
2012-12-04 2012 Communication on Progress Active
2011-12-05 2011 Communication on Progress Active

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.